To access this element change to forms mode OFF
Grant Award View - GA65963
Treg cell therapy for the treatment of vision-threatening neovascular...
GA ID:
GA65963
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$1,396,936.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Treg cell therapy for the treatment of vision-threatening neovascular retinopathies
Purpose:
Vision loss and blindness due to prematurity, diabetes and ageing is escalating in prevalence across the globe, yet treatments are limited, often ineffective and target severe disease rather than prevention. Our team recently discovered that increasing a certain immune cell that has powerful anti-inflammatory actions, results in these cells reaching the eye and reducing damage to the retina. We will explore this concept to develop effective treatments for vision-threatening diseases.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1181462
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA